Sutro Biopharma, Inc.

North America Legal Chronicle. December 23, 2022

Sutro Biopharma’s Option Grant Agreement with Vaxcyte

By Martina Bellini

Fenwick represented Sutro Biopharma on the deal. Sutro Biopharma (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), announced its option grant...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. June 29, 2022

Sutro Biopharma’s Strategic Collaboration with Astellas

By Martina Bellini

Fenwick represented Sutro Biopharma, Inc. on the deal. Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage oncology company, announced its strategic collaboration and licensing agreement with Astellas Pharma...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

American Tower’s $1.2 Billion Notes Offering

Rising Dragon Acquisition Corp.’s $57.5 Million Initial Public Offering

Bloomberg’s Expansion Lease with SL Green Realty

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

TuSueldoYa’s Capital Increase

Eneva’s Acquisition of Tevisa Termelétrica Viana, Povoação Energia, Linhares Brasil Energia Participações, and 50% of Geradora de Energia do Maranhão

Symrise’s Public Offer for Probi

Eleven Ventures’ Investment in Cloud Office

European Investment Bank’s €100 Million Digital Bonds Issuance

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Vee Healthtek’s Investment Round

Synthimed Labs’ Acquisition of Ind Swift Laboratories

Kakatiya Expressway’s Financing Round

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Sutro Biopharma’s Option Grant Agreement with Vaxcyte

Standard 1 Year Membership Required

Sutro Biopharma’s Strategic Collaboration with Astellas

Standard 1 Year Membership Required